Clinical Trials

Showing trials with last updates posted in 2021.

NCT01755208 | TERMINATED | NA
110 participants

Light-Scattering Spectroscopy for Detection of Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2021-11-19
Start Date:
2012-11-21
Completion:
2020-11-19
Conditions
  • Healthy, no Evidence of Disease
  • Stage II Breast Cancer
  • Stage IIIA Breast Cancer
  • Stage IIIB Breast Cancer
  • Stage IIIC Breast Cancer
Interventions
  • PROCEDURE
No Results Yet
NCT01535924 | COMPLETED | PHASE1/PHASE2
26 participants

Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2021-11-19
Start Date:
2012-02-09
Completion:
2019-02-20
Conditions
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • Adult Lymphocyte Predominant Hodgkin Lymphoma
  • Adult Mixed Cellularity Hodgkin Lymphoma
  • Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma
  • Adult Nodular Sclerosis Hodgkin Lymphoma
  • Recurrent Adult Hodgkin Lymphoma
Interventions
  • DRUG
NCT01321541 | COMPLETED | PHASE3
312 participants

Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant

Study Type:
INTERVENTIONAL
Last Updated:
2021-11-19
Start Date:
2011-04-20
Completion:
2018-06-28
Conditions
  • Diffuse Large B-cell Lymphoma
  • de Novo DLBCL
  • DLBCL Transformed From Indolent Lymphoma
  • Follicular Grade 3 Lymphoma
Interventions
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page